MedTrace Logo

Multicenter Pheochromocytoma and Paraganglioma Evaluation

NCT03344016 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1148

Last updated 2020-07-09

No results posted yet for this study

Summary

Target population:

Patients with (1) newly diagnosed or (2) past history of pheochromocytomas and paragangliomas (PPGL) or (3) carrier of genetic mutations in known PPGL susceptibility genes.

International multicenter prospective cohort study with randomized intervention (special care follow-up vs. standard care follow-up).

All patients will receive instructions about follow-up at the time point of study inclusion. Patients randomized to the standard care follow-up group will be advised to return annually for follow-up according to current routine practice (without active re-scheduling). In contrast, patients randomized to the special care follow-up group will also be advised to return annually for follow-up but these patients will be actively invited, re-scheduled and reminded by the centers to meet scheduled follow-up appointments.

Conditions

  • Pheochromocytoma
  • Paraganglioma

Interventions

OTHER

Contact by clinical center

Patients will be acitvely contacted by the clinical center for follow-up procedure

Sponsors & Collaborators

  • Technische Universität Dresden

    collaborator OTHER

  • Wuerzburg University Hospital

    collaborator OTHER

  • University of Zurich

    collaborator OTHER

  • Radboud University Medical Center

    collaborator OTHER

  • Lübeck University Clinic

    collaborator OTHER

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • Felix Beuschlein

    lead OTHER

Principal Investigators

  • Felix Beuschlein, M.D. · University of Zurich

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2035-11-01
Completion
2040-11-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03344016 on ClinicalTrials.gov